Suchergebnisse - "Smare, Caitlin"

PubPharm (13)

1

Cost-Effectiveness of Cemiplimab Versus Standard of Care in the United States for First-Line Treatment of Advanced Non-small Cell Lung Cancer With Programmed Death-Ligand 1 Expression ≥50

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2022

von Kuznik, A. | Smare, C. | Chen, C. | +9

2

Cost-effectiveness of nivolumab in patients with NSCLC in the United States

enthalten in: The American journal of managed care | 2021

von Chaudhary, M. | Lubinga, S. | Smare, C. | +2

3

Cost-effectiveness of nivolumab monotherapy in the third-line treatment of small cell lung cancer

enthalten in: Journal of medical economics | 2021

von Smare, C. | Dave, K. | Juarez-Garcia, A. | +4

4

Cost-effectiveness of nivolumab in squamous and non-squamous non-small cell lung cancer in Canada and Sweden : an update with 5-year data

enthalten in: Journal of medical economics | 2021

von Chaudhary, M. | Holmberg, C. | Lakhdari, K. | +4

5

The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK

enthalten in: Respiratory medicine | 2020

von FitzGerald, J. | Arnetorp, S. | Smare, C. | +5

6

Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis : Estimating and Comparing Survival Outcomes

enthalten in: PharmacoEconomics | 2020

von Smare, C. | Lakhdari, K. | Doan, J. | +2

7

Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes

enthalten in: PharmacoEconomics | 2019

von Smare, C. | Lakhdari, K. | Doan, J. | +2

8

Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes

enthalten in: PharmacoEconomics | 2019

von Smare, C. | Lakhdari, K. | Doan, J. | +2

9

Evaluating Partitioned Survival and Markov Decision-Analytic Modeling Approaches for Use in Cost-Effectiveness Analysis: Estimating and Comparing Survival Outcomes

enthalten in: PharmacoEconomics | 2019

von Smare, C. | Lakhdari, K. | Doan, J. | +2

10

Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries

enthalten in: BMC health services research | 2017

von Lu, X. | Smare, C. | Kambili, C. | +2